Illumina Inc (ILMN) 237.54 $ILMN
Illumina Stock Dives As Q2 Earnings Beat, Sales Miss
at Investor's Business Daily - Tue Jul 21, 5:58PM CDT
Gene-sequencing giant Illumina beat analysts' Q2 earnings estimates Tuesday but missed on revenue for the first time in six years, sending shares down 9.5% in after-hours trading. Illumina (ILMN) said income excluding one-time items amounted to 80...
ILMN: 237.54 (-2.48)
Key Takeaways from Ilumina's (ILMN) Q2 Earnings - Stocks in the News
Maher Syed - Zacks Investment Research - Tue Jul 21, 5:07PM CDT
Why are Ilumina shares down 8% in after hour trading today?
ILMN: 237.54 (-2.48)
Illumina Inc.'s Q2 Results Fall Short
Keith Speights, The Motley Fool - Motley Fool - Tue Jul 21, 5:03PM CDT
Source: Illumina Judging from Illumina 's after-hours drop of nearly 11% on Tuesday before its partial recovery, you might think the genomic sequencing company reported horrible second quarter financial results. That wasn't really the case,...
ILMN: 237.54 (-2.48)
GoPro, Fitbit Surge As Indexes Dip; Apple Down Late
at Investor's Business Daily - Tue Jul 21, 4:19PM CDT
Stocks slumped Tuesday, but closed off session lows. The Dow Jones industrial average slid 1%, hurt by earnings weakness in its components IBM (IBM) and United Technologies Group (UTX). The Nasdaq closed down 0.2%, and the S&P 500 trimmed 0.4%....
FIT: 46.87 (+2.40), GPRO: 62.04 (+1.24), TSLA: 266.77 (-15.49), IBM: 163.07 (-10.15), UTX: 102.71 (-7.77), CMG: 673.07 (-4.93), ILMN: 237.54 (-2.48), MSFT: 47.28 (+0.36), AAPL: 130.75 (-1.32)
Market Wrap: IBM and United Tech a Real Drag
at The Street - Tue Jul 21, 3:44PM CDT
IBM and UTX accounted for two-thirds of the Dow's 1% drop, and Apple and Microsoft fall after-hours..
KO: 41.19 (-0.19), ABT: 49.76 (-0.30), IBM: 163.07 (-10.15), UTX: 102.71 (-7.77), CMG: 673.07 (-4.93), STJ: 76.71 (+0.14), ILMN: 237.54 (-2.48), THOR: 57.58 (+8.77), EMC: 24.93 (-0.05), BA: 145.00 (-1.72), MSFT: 47.28 (+0.36), AAPL: 130.75 (-1.32), LOCK: 8.15 (-7.91), LXK: 37.75 (-9.57)
Illumina beats 2Q profit forecasts
Automated Insights - Tue Jul 21, 3:24PM CDT
SAN DIEGO (AP) _ Illumina Inc. (ILMN) on Tuesday reported second-quarter earnings of $102.2 million.
ILMN: 237.54 (-2.48)
Market Is Showing Its Underlying Weakness
at The Street - Tue Jul 21, 3:24PM CDT
Indices haven't reflected stocks' overall health.
ISRG: 505.09 (+7.48), NFLX: 112.51 (+1.96), YHOO: 39.73 (+0.19), GPRO: 62.04 (+1.24), TSLA: 266.77 (-15.49), IBM: 163.07 (-10.15), FB: 98.39 (+0.48), CMG: 673.07 (-4.93), ILMN: 237.54 (-2.48), GOOGL: 695.35 (+2.51), MSFT: 47.28 (+0.36), MBLY: 60.57 (-0.48), AAPL: 130.75 (-1.32)
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2015
Business Wire - Tue Jul 21, 3:05PM CDT
Illumina, Inc. (NASDAQ:ILMN) today announced its financial results for the second quarter of fiscal year 2015.
ILMN: 237.54 (-2.48)
What's in Store at Quest Diagnostics (DGX) this Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 21, 1:10PM CDT
Last quarter, Quest Diagnostics (DGX) had delivered a positive earnings surprise of 2.94%
DGX: 72.09 (-1.00), ILMN: 237.54 (-2.48), AMED: 43.55 (-0.27), XRAY: 52.13 (-0.36)
Bright Idea: Take Some Illumina Off The Table
at The Street - Tue Jul 21, 11:00AM CDT
After a strong run for the maker of scientific tools, investors may be vulnerable to a correction.
ILMN: 237.54 (-2.48)
Stock Futures Mixed, IBM Weighs; Infosys, Tesla, Apple In Motion
at Investor's Business Daily - Tue Jul 21, 8:03AM CDT
The world looked a bit flat from a market standpoint early Tuesday, with global markets and commodities largely unmoved and stock futures steering the U.S. market toward a mixed open. Dow futures were down 65.4 points, with IBM (IBM) pulling hard to...
TSLA: 266.77 (-15.49), GPRO: 62.04 (+1.24), LMT: 203.15 (-1.98), ABX: 7.50 (+0.09), UTX: 102.71 (-7.77), NEM: 18.74 (+0.58), ILMN: 237.54 (-2.48), INFY: 17.06 (+1.29), YHOO: 39.73 (+0.19), AEM: 23.34 (+0.62), IBM: 163.07 (-10.15), CMG: 673.07 (-4.93), HAWK: 42.65 (-0.25), MSFT: 47.28 (+0.36), AUY: 2.15 (+0.03), VZ: 46.97 (-1.13), TRV: 104.48 (+1.87)
Illumina appoints Sanjay Chikarmane as SVP and general manager of Enterprise Informatics
M2 - Tue Jul 21, 4:12AM CDT
Human health company Illumina (NasdaqGS:ILMN) revealed on Monday that it has appointed Sanjay Chikarmane as senior vice president and general manager of its Enterprise Informatics business.
ILMN: 237.54 (-2.48)
Earnings Loom For Handful Of Top Big Cap 20 Stocks
at Investor's Business Daily - Mon Jul 20, 5:50PM CDT
A handful of Big Cap 20 stocks are due to report quarterly earnings this week, but only one is expected to post accelerating profit growth. Starbucks (SBUX) will report fiscal Q3 earnings Thursday. Profit is seen rising 21% to 41 cents a share, which...
SBUX: 56.20 (-0.01), BIIB: 409.50 (+0.57), ILMN: 237.54 (-2.48), ABBV: 70.54 (-0.26), CELG: 136.24 (+1.01)
Illumina Names Sanjay Chikarmane as Senior Vice President and General Manager of Enterprise Informatics
Business Wire - Mon Jul 20, 3:05PM CDT
Illumina Inc. (NASDAQ:ILMN) today announced that Sanjay Chikarmane has been named Senior Vice President and General Manager of Illumina's Enterprise Informatics business. Chikarmane will lead the development and commercialization of products and services aimed at turning genomic data into actionable information for researchers and clinicians. He will report to Illumina President, Francis deSouza.
ILMN: 237.54 (-2.48)
Will Mead Johnson's (MJN) Q2 Earnings Disappoint Investors? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 20, 1:15PM CDT
Last quarter, Mead Johnson (MJN) had delivered a positive earnings surprise of 4.81%.
MJN: 88.13 (+0.32), ILMN: 237.54 (-2.48), AMED: 43.55 (-0.27), XRAY: 52.13 (-0.36)
3 Stocks to Take Advantage of the Rise in Personalized Medicine
Dan Caplinger, Keith Speights, and Cheryl Swanson, The Motley Fool - Motley Fool - Sat Jul 18, 8:06AM CDT
Image: Centers for Disease Control via Facebook. For centuries, medical advances focused on protecting large populations with one-size-fits-all treatments. But more recently, personalized medicine has become an increasingly important part of...
ILMN: 237.54 (-2.48), EXAS: 25.15 (-1.88)
Move Aside Apple: 8 IBD 50 Stocks With Earnings Due
at Investor's Business Daily - Sat Jul 18, 7:02AM CDT
Earnings season is now in high gear, with all eyes on Apple's (AAPL) report Tuesday. While the iPhone maker should deliver another quarter of solid profit and sales growth, Apple isn't on the IBD 50 list of the very best stocks. In the coming week,...
SBUX: 56.20 (-0.01), ABC: 114.10 (-0.66), VRX: 240.59 (+0.71), RCPT: 228.98 (+0.26), ILMN: 237.54 (-2.48), HAWK: 42.65 (-0.25), MANH: 62.33 (-0.17), ALK: 74.95 (+0.81), AAPL: 130.75 (-1.32), CELG: 136.24 (+1.01)
Newfound Market Strength Could Benefit These IBD 50 Names
at Investor's Business Daily - Fri Jul 17, 5:48PM CDT
The stock market often does what's least expected, and that certainly has been the case lately. Consider these four recent occurrences: A heavy distribution-day count for the Nasdaq and S&P 500 in recent weeks didn't do much damage to the market. In...
CNC: 71.78 (-2.82), AMBA: 118.18 (+0.46), MNST: 144.05 (+1.30), VRX: 240.59 (+0.71), ILMN: 237.54 (-2.48), RCPT: 228.98 (+0.26), HAWK: 42.65 (-0.25), FLTX: 49.64 (-0.24), REGN: 560.00 (-1.17), CELG: 136.24 (+1.01)
Illumina (ILMN) Stock Gained on Coverage Initiation at Canaccord
at The Street - Fri Jul 17, 3:44PM CDT
Shares of Illumina (ILMN) closed up after Canaccord initiated its coverage at $275 price target and a 'buy' rating.
ILMN: 237.54 (-2.48)
Can Illumina (ILMN) Continue its Earnings Streak in Q2? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 17, 1:15PM CDT
Illumina's (ILMN) management expects to significantly expand its market share in China, in terms of placements, through the remaining quarters of 2015
ZLTQ: 31.27 (-0.19), ALGN: 65.16 (-0.88), ILMN: 237.54 (-2.48), XRAY: 52.13 (-0.36)
Illumina Stock Dives As Q2 Earnings Beat, Sales Miss
at Investor's Business Daily - Tue Jul 21, 5:58PM CDT
Gene-sequencing giant Illumina beat analysts' Q2 earnings estimates Tuesday but missed on revenue for the first time in six years, sending shares down 9.5% in after-hours trading. Illumina (ILMN) said income excluding one-time items amounted to 80...
ILMN: 237.54 (-2.48)
Key Takeaways from Ilumina's (ILMN) Q2 Earnings - Stocks in the News
Maher Syed - Zacks Investment Research - Tue Jul 21, 5:07PM CDT
Why are Ilumina shares down 8% in after hour trading today?
ILMN: 237.54 (-2.48)
Illumina Inc.'s Q2 Results Fall Short
Keith Speights, The Motley Fool - Motley Fool - Tue Jul 21, 5:03PM CDT
Source: Illumina Judging from Illumina 's after-hours drop of nearly 11% on Tuesday before its partial recovery, you might think the genomic sequencing company reported horrible second quarter financial results. That wasn't really the case,...
ILMN: 237.54 (-2.48)
GoPro, Fitbit Surge As Indexes Dip; Apple Down Late
at Investor's Business Daily - Tue Jul 21, 4:19PM CDT
Stocks slumped Tuesday, but closed off session lows. The Dow Jones industrial average slid 1%, hurt by earnings weakness in its components IBM (IBM) and United Technologies Group (UTX). The Nasdaq closed down 0.2%, and the S&P 500 trimmed 0.4%....
FIT: 46.87 (+2.40), GPRO: 62.04 (+1.24), TSLA: 266.77 (-15.49), IBM: 163.07 (-10.15), UTX: 102.71 (-7.77), CMG: 673.07 (-4.93), ILMN: 237.54 (-2.48), MSFT: 47.28 (+0.36), AAPL: 130.75 (-1.32)
Market Wrap: IBM and United Tech a Real Drag
at The Street - Tue Jul 21, 3:44PM CDT
IBM and UTX accounted for two-thirds of the Dow's 1% drop, and Apple and Microsoft fall after-hours..
KO: 41.19 (-0.19), ABT: 49.76 (-0.30), IBM: 163.07 (-10.15), UTX: 102.71 (-7.77), CMG: 673.07 (-4.93), STJ: 76.71 (+0.14), ILMN: 237.54 (-2.48), THOR: 57.58 (+8.77), EMC: 24.93 (-0.05), BA: 145.00 (-1.72), MSFT: 47.28 (+0.36), AAPL: 130.75 (-1.32), LOCK: 8.15 (-7.91), LXK: 37.75 (-9.57)
Illumina beats 2Q profit forecasts
Automated Insights - Tue Jul 21, 3:24PM CDT
SAN DIEGO (AP) _ Illumina Inc. (ILMN) on Tuesday reported second-quarter earnings of $102.2 million.
ILMN: 237.54 (-2.48)
Market Is Showing Its Underlying Weakness
at The Street - Tue Jul 21, 3:24PM CDT
Indices haven't reflected stocks' overall health.
ISRG: 505.09 (+7.48), NFLX: 112.51 (+1.96), YHOO: 39.73 (+0.19), GPRO: 62.04 (+1.24), TSLA: 266.77 (-15.49), IBM: 163.07 (-10.15), FB: 98.39 (+0.48), CMG: 673.07 (-4.93), ILMN: 237.54 (-2.48), GOOGL: 695.35 (+2.51), MSFT: 47.28 (+0.36), MBLY: 60.57 (-0.48), AAPL: 130.75 (-1.32)
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2015
Business Wire - Tue Jul 21, 3:05PM CDT
Illumina, Inc. (NASDAQ:ILMN) today announced its financial results for the second quarter of fiscal year 2015.
ILMN: 237.54 (-2.48)
What's in Store at Quest Diagnostics (DGX) this Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 21, 1:10PM CDT
Last quarter, Quest Diagnostics (DGX) had delivered a positive earnings surprise of 2.94%
DGX: 72.09 (-1.00), ILMN: 237.54 (-2.48), AMED: 43.55 (-0.27), XRAY: 52.13 (-0.36)
Bright Idea: Take Some Illumina Off The Table
at The Street - Tue Jul 21, 11:00AM CDT
After a strong run for the maker of scientific tools, investors may be vulnerable to a correction.
ILMN: 237.54 (-2.48)
Stock Futures Mixed, IBM Weighs; Infosys, Tesla, Apple In Motion
at Investor's Business Daily - Tue Jul 21, 8:03AM CDT
The world looked a bit flat from a market standpoint early Tuesday, with global markets and commodities largely unmoved and stock futures steering the U.S. market toward a mixed open. Dow futures were down 65.4 points, with IBM (IBM) pulling hard to...
TSLA: 266.77 (-15.49), GPRO: 62.04 (+1.24), LMT: 203.15 (-1.98), ABX: 7.50 (+0.09), UTX: 102.71 (-7.77), NEM: 18.74 (+0.58), ILMN: 237.54 (-2.48), INFY: 17.06 (+1.29), YHOO: 39.73 (+0.19), AEM: 23.34 (+0.62), IBM: 163.07 (-10.15), CMG: 673.07 (-4.93), HAWK: 42.65 (-0.25), MSFT: 47.28 (+0.36), AUY: 2.15 (+0.03), VZ: 46.97 (-1.13), TRV: 104.48 (+1.87)
Illumina appoints Sanjay Chikarmane as SVP and general manager of Enterprise Informatics
M2 - Tue Jul 21, 4:12AM CDT
Human health company Illumina (NasdaqGS:ILMN) revealed on Monday that it has appointed Sanjay Chikarmane as senior vice president and general manager of its Enterprise Informatics business.
ILMN: 237.54 (-2.48)
Earnings Loom For Handful Of Top Big Cap 20 Stocks
at Investor's Business Daily - Mon Jul 20, 5:50PM CDT
A handful of Big Cap 20 stocks are due to report quarterly earnings this week, but only one is expected to post accelerating profit growth. Starbucks (SBUX) will report fiscal Q3 earnings Thursday. Profit is seen rising 21% to 41 cents a share, which...
SBUX: 56.20 (-0.01), BIIB: 409.50 (+0.57), ILMN: 237.54 (-2.48), ABBV: 70.54 (-0.26), CELG: 136.24 (+1.01)
Illumina Names Sanjay Chikarmane as Senior Vice President and General Manager of Enterprise Informatics
Business Wire - Mon Jul 20, 3:05PM CDT
Illumina Inc. (NASDAQ:ILMN) today announced that Sanjay Chikarmane has been named Senior Vice President and General Manager of Illumina's Enterprise Informatics business. Chikarmane will lead the development and commercialization of products and services aimed at turning genomic data into actionable information for researchers and clinicians. He will report to Illumina President, Francis deSouza.
ILMN: 237.54 (-2.48)
Will Mead Johnson's (MJN) Q2 Earnings Disappoint Investors? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 20, 1:15PM CDT
Last quarter, Mead Johnson (MJN) had delivered a positive earnings surprise of 4.81%.
MJN: 88.13 (+0.32), ILMN: 237.54 (-2.48), AMED: 43.55 (-0.27), XRAY: 52.13 (-0.36)
3 Stocks to Take Advantage of the Rise in Personalized Medicine
Dan Caplinger, Keith Speights, and Cheryl Swanson, The Motley Fool - Motley Fool - Sat Jul 18, 8:06AM CDT
Image: Centers for Disease Control via Facebook. For centuries, medical advances focused on protecting large populations with one-size-fits-all treatments. But more recently, personalized medicine has become an increasingly important part of...
ILMN: 237.54 (-2.48), EXAS: 25.15 (-1.88)
Move Aside Apple: 8 IBD 50 Stocks With Earnings Due
at Investor's Business Daily - Sat Jul 18, 7:02AM CDT
Earnings season is now in high gear, with all eyes on Apple's (AAPL) report Tuesday. While the iPhone maker should deliver another quarter of solid profit and sales growth, Apple isn't on the IBD 50 list of the very best stocks. In the coming week,...
SBUX: 56.20 (-0.01), ABC: 114.10 (-0.66), VRX: 240.59 (+0.71), RCPT: 228.98 (+0.26), ILMN: 237.54 (-2.48), HAWK: 42.65 (-0.25), MANH: 62.33 (-0.17), ALK: 74.95 (+0.81), AAPL: 130.75 (-1.32), CELG: 136.24 (+1.01)
Newfound Market Strength Could Benefit These IBD 50 Names
at Investor's Business Daily - Fri Jul 17, 5:48PM CDT
The stock market often does what's least expected, and that certainly has been the case lately. Consider these four recent occurrences: A heavy distribution-day count for the Nasdaq and S&P 500 in recent weeks didn't do much damage to the market. In...
CNC: 71.78 (-2.82), AMBA: 118.18 (+0.46), MNST: 144.05 (+1.30), VRX: 240.59 (+0.71), ILMN: 237.54 (-2.48), RCPT: 228.98 (+0.26), HAWK: 42.65 (-0.25), FLTX: 49.64 (-0.24), REGN: 560.00 (-1.17), CELG: 136.24 (+1.01)
Illumina (ILMN) Stock Gained on Coverage Initiation at Canaccord
at The Street - Fri Jul 17, 3:44PM CDT
Shares of Illumina (ILMN) closed up after Canaccord initiated its coverage at $275 price target and a 'buy' rating.
ILMN: 237.54 (-2.48)
Can Illumina (ILMN) Continue its Earnings Streak in Q2? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 17, 1:15PM CDT
Illumina's (ILMN) management expects to significantly expand its market share in China, in terms of placements, through the remaining quarters of 2015
ZLTQ: 31.27 (-0.19), ALGN: 65.16 (-0.88), ILMN: 237.54 (-2.48), XRAY: 52.13 (-0.36)
